A preliminary open study of topical cyclosporin for hypertrophic lichen planus
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 1 (1) , 39-41
- https://doi.org/10.3109/09546638909086688
Abstract
Four patients with chronic hypertrophic lichen planus were treated with daily applications of 5 per cent w/v cyclosporin intravenous solution under polythene occlusions for a month. Biopsies were taken before and after treatment for routine histology and cell marker studies. Cyclosporin concentrations were measured in lesional skin and whole blood to assess tissue penetration. Scaling improved in all patients, plaques were subjectively thinner in three, and irritation lessened in two. One patient showed a striking reduction in the intensity of inflammatory infiltrate after topical cyclosporin. Dermat T-lymphocyte helper to suppressor ratios were reduced after cyclosporin in two patients, and HLA-DR expression was diminished, both in Dermat lymphocytes and keratinocytes, in three. Cyclosporin was not detected in blood or skin.Keywords
This publication has 7 references indexed in Scilit:
- Long-term cyclosporin for psoriasisBritish Journal of Dermatology, 1989
- Severe Atopic Eczema: Response to Oral Cyclosporin AJournal of the Royal Society of Medicine, 1988
- INTRALESIONAL INJECTION OF CYCLOSPORIN IN PSORIASISThe Lancet, 1988
- TOPICAL CYCLOSPORIN AND PSORIASISThe Lancet, 1987
- Efficacy of Low-Dose Cyclosporine in Severe Atopic Skin DiseaseArchives of Dermatology, 1987
- CYCLOSPORIN FOR PSORIASISThe Lancet, 1984